Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eagle Pharmaceuticals
(NQ:
EGRX
)
4.370
-0.240 (-5.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eagle Pharmaceuticals
< Previous
1
2
3
4
Next >
Eagle Pharmaceuticals Reports First Quarter 2021 Results
May 10, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion (“RI”) Liquid Formulation in Japan
May 10, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of Directors
May 03, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination with Rituximab for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma Receives PMDA Approval in Japan
April 30, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021
April 29, 2021
From
Eagle Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.